scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046099735 |
P356 | DOI | 10.1186/1471-2407-14-880 |
P932 | PMC publication ID | 4289215 |
P698 | PubMed publication ID | 25427715 |
P5875 | ResearchGate publication ID | 268875293 |
P50 | author | Armando Felsani | Q30016277 |
Anna Moles | Q43444259 | ||
Francesca Megiorni | Q56999323 | ||
Antonio Pizzuti | Q56999334 | ||
P2093 | author name string | Barry Pizer | |
Alessandro Guffanti | |||
Carlo Dominici | |||
Samantha Cialfi | |||
Anna Clerico | |||
Heather P McDowell | |||
Alessandra De Grazia | |||
Simona Camero | |||
P2860 | cites work | MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia | Q21092263 |
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions | Q24319987 | ||
A scaling normalization method for differential expression analysis of RNA-seq data | Q24628783 | ||
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells | Q24632284 | ||
miRBase: tools for microRNA genomics | Q24649872 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
MicroRNA signatures in human cancers | Q27860962 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 | ||
Epigenetics in human disease and prospects for epigenetic therapy | Q29547437 | ||
Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome | Q29616819 | ||
MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation | Q30426550 | ||
C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. | Q31135850 | ||
Small-sample estimation of negative binomial dispersion, with applications to SAGE data | Q33295482 | ||
A human functional protein interaction network and its application to cancer data analysis | Q33581341 | ||
Structure and activity of putative intronic miRNA promoters | Q33658452 | ||
MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis | Q33688560 | ||
Rhabdomyosarcoma--working out the pathways | Q33739291 | ||
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas | Q33906031 | ||
miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway | Q39648802 | ||
Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives. | Q39767891 | ||
Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells | Q39915669 | ||
The role of the insulin-like growth factor-I receptor in cancer | Q40374636 | ||
Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells | Q41703024 | ||
microRNA expression profiles in human colorectal cancers with brain metastases | Q41787586 | ||
Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. | Q43118412 | ||
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors | Q45887164 | ||
Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation | Q46990480 | ||
MicroRNA expression signature of human sarcomas | Q47836377 | ||
MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. | Q54340906 | ||
Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma. | Q55470455 | ||
DNA methylation and cancer | Q74559063 | ||
Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis | Q34110794 | ||
Association of alveolar rhabdomyosarcoma with the Beckwith-Wiedemann syndrome. | Q34112667 | ||
MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. | Q34159602 | ||
The Intergroup Rhabdomyosarcoma Study-I. A final report | Q34171661 | ||
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes | Q34186822 | ||
Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. | Q34204305 | ||
Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects | Q34371040 | ||
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma | Q34405491 | ||
Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors | Q34441929 | ||
Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs | Q34533056 | ||
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia | Q34615087 | ||
Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. | Q34722597 | ||
New entities, concepts, and questions in childhood tumor pathology | Q34731742 | ||
Molecular pathogenesis of rhabdomyosarcoma | Q34779149 | ||
A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR. | Q35037288 | ||
Update on childhood rhabdomyosarcoma | Q35090205 | ||
A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival | Q35921672 | ||
Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. | Q36279936 | ||
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 | ||
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. | Q37331364 | ||
miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. | Q37428692 | ||
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein | Q37622891 | ||
MicroRNAs and cancer: towards a personalized medicine | Q38103918 | ||
MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. | Q38118222 | ||
Potential microRNA targets for cancer chemotherapy | Q38120009 | ||
NOA: a novel Network Ontology Analysis method | Q38502454 | ||
Identification of BMP2 as an epigenetically silenced growth inhibitor in rhabdomyosarcoma. | Q39019402 | ||
Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer | Q39035575 | ||
TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma | Q39153280 | ||
MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer | Q39207834 | ||
miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. | Q39228419 | ||
Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. | Q39273744 | ||
Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma | Q39397196 | ||
Role of epigenetic modulation for the treatment of sarcoma. | Q39405196 | ||
P4510 | describes a project that uses | edgeR | Q113334690 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
rhabdomyosarcoma | Q1898141 | ||
P304 | page(s) | 880 | |
P577 | publication date | 2014-11-25 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members | |
P478 | volume | 14 |
Q39996382 | A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas |
Q38668249 | An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma |
Q34494731 | Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression |
Q39266150 | DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. |
Q38749559 | Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma |
Q93050593 | Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia |
Q26801952 | Head and neck rhabdomyosarcoma: follow-up results of four cases and review of the literature |
Q38725853 | MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. |
Q38552358 | MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game. |
Q41860642 | MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia |
Q91742650 | MicroRNA-29 family inhibits rhabdomyosarcoma formation and progression by regulating GEFT function |
Q64087608 | MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT |
Q41660637 | MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review |
Q57792112 | PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines |
Q55416010 | PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study. |
Q47848908 | Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells. |
Q37660794 | Specific and Novel microRNAs Are Regulated as Response to Fungal Infection in Human Dendritic Cells |
Q88780301 | Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines |
Q26770132 | The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology |
Q33868794 | The roles of microRNA families in hepatic fibrosis |
Q35932634 | miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. |
Q55090271 | miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. |
Q92738426 | miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17 |